Cite
HARVARD Citation
Bundschuh, R. et al. (2023). 177Lu-rhPSMA-10.1 Induces Tumor Response in a Patient With mCRPC After PSMA-Directed Radioligand Therapy With 177Lu-PSMA-I&T. Clinical nuclear medicine. pp. 337-338. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bundschuh, R. et al. (2023). 177Lu-rhPSMA-10.1 Induces Tumor Response in a Patient With mCRPC After PSMA-Directed Radioligand Therapy With 177Lu-PSMA-I&T. Clinical nuclear medicine. pp. 337-338. [Online].